Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection

Sophie Clarke(Imperial College London), Waljit S. Dhillo(Imperial College London), Tricia Tan(Imperial College London), Beatrice Muzi(Imperial College London), Karim Meeran(Imperial College Healthcare NHS Trust), Chioma Izzi‐Engbeaya(Hammersmith Hospital), Bernard Khoo(University College London), Alexander Comninos(National Health Service), Maria Phylactou(Imperial College London), Ali Abbara(National Health Service), Bijal Patel(National Health Service), Edouard Mills(Imperial College Healthcare NHS Trust), Sirazum Choudhury(Imperial College Healthcare NHS Trust)
The Journal of Clinical Endocrinology & Metabolism
May 19, 2021
10.1210/clinem/dgab349
Cited by 74

Related Papers

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
|JAMA|2018|406
Association between high serum total cortisol concentrations and mortality from COVID-19
|The Lancet Diabetes & Endocrinology|2020|260
Male infertility due to testicular disorders
|The Journal of Clinical Endocrinology & Metabolism|2020|246
Thyroid Function Before, During, and After COVID-19
|The Journal of Clinical Endocrinology & Metabolism|2020|220
Neurokinin B Administration Induces Hot Flushes in Women
|Scientific Reports|2015|161